Community

Your AGA Research Foundation Gifts Support …

Evan Dellon, MD, MPH, at the University of North Carolina, Chapel Hill received the 2012 June and Donald O. Castell, MD, Esophageal Clinical Research Award. The award provides an opportunity for him to continue to develop familiarity with translational research techniques and work toward his goal of combining these techniques with epidemiologic, clinical and endoscopic research methods.
Read More

 

Latest from Twitter

AmerGastroAssn: Celiac patients have nearly 3-fold increased risk of developing pancreatitis, according to a new CGH study: http://t.co/BdJZb1HB


AmerGastroAssn: Oct Gastro podcast: Dr. Rebecca Fitzgerald discusses new risk-stratification biomarker panel for Barrett's http://t.co/EmQRGCDz


AmerGastroAssn: Show your colleagues you appreciate what they do. Nominate them for AGA Member Recognition Prizes. http://t.co/JLCCFhYL


Latest from YouTube

Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury...


A Genetic Screen Identifies Interferon Alfa Effector Genes Required to Suppress Hepatitis C...


Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With...


Latest from Facebook

Early bird registration for the 2013 James W. Freston conference ends today. Thi...


Some of our favorite moments from DDW 2013!


We had a packed house at Sunday's AGA Trainee & Young GI Networking Reception. H...


Investing in the Future — Promoting Diversity in GI Training

Thank you to our presenters and attendees who participated in the AGA/ASGE collaborative program, “Investing in the Future — Promoting Diversity in GI Training.” Its aim was to promote and develop diversity amongst those who enter the field of digestive diseases. View Photos

Clinical Question of the Month

How strong is your clinical knowledge?

AGA introduces a new interactive, fun contest that tests your current knowledge of gastroenterology, hepatology and nutrition each month for a chance to win a valuable prize.

Learn More

Journal Club

Efficacy of Ceftriaxone or Mero-
penem as Initial Therapies in Whipple's Disease

This was a randomized controlled trial to show that treatment with ceftriaxone or meropenem, followed by trimethoprim–sulfamethoxazole, cures patients with Whipple's disease.

Read More

View All

Classifieds

For as little as $82.50, you can place a classifed ad of 100 words or less in AGA's weekly e-mail newsletter, AGA eDigest, or AGA's bi-monthly magazine, AGA Perspectives. If you place ads in both AGA Perspectives and AGA eDigest, you will receive a 10 percent discount. Advertising in either inlcudes a free online classified listing.

Learn More

Get Involved

Submit an application for committee service, nominate a colleague for a leadership position or award.

Learn More